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Abstract
DEVELOPMENT OF A MATHEMATICAL MODEL OF RENAL
FUNCTION FOR CLINICAL APPLICATION
by
Barbara A. Holshouser
This model describes the orthoiodohippurate (OIH) distribution and 
clearance in the renovascular system. The model is described by five
compartments: the blood, left and right kidneys, bladder and the red 
Data for these compartments, except the RBCblood cell compartment.
compartment, are collected with scintillation detectors monitoring OIH 
tagged with 1-131 as the radiopharmaceutical passes through each 
compartment. Time/ activity curves are plotted for the data and used as 
inputs to the model parameter estimation routine. The compartments are 
described by a set of first order ordinary differential equations solved 
using the Adam's methods. For parameter estimation, an iterative 
predictor-corrector procedure is used. The estimated model parameters
are used to calculate total and differential effective renal plasma flows 
which are compared to standard PAH clearance tests. A blood-to-urine
flow index, defined in this research using these parameters, and a
cortex-to-medulla transit is also used to evaluate various renal diseases
surgically induced in animal models. The predicted effective renal
plasma flows correlate well with the PAH clearances for both normal and 
abnormal conditions and the blood-to-urine flow index is particularly 
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The purpose of the mathematical model presented in this 
dissertation is to describe and/or quantitate some aspects of renal 
function. In the future, we hope to use this model clinically in the 
nuclear medicine laboratory to aid physicians in diagnosing and 
evaluating renal diseases in patients.
In Chapter 1, this dissertation summarizes previous work done in 
this area. Chapter 2 describes the five compartment renal model used in 
this research and the solution of the equations representing the model. 
Chapter 3 presents the protocol used for the animal experiments, the 
results and a discussion of the results. Chapter 4 summarizes and draws 
conclusions, as well as, states the extensions of this research for
future work.
Many people were involved in completing this research and thanks 
must go to all of them. In particular, thanks go to Dr. Kirk for many
hours of catheterizations and to Dr. Grames for much needed advice and
evaluation of the data. Thanks must also go to Dr. Yakush and Dr. 
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CHAPTER 1
ANATOMICAL AND PHYSIOLOGICAL SUMMARYRENAL SYSTEM:
AND REVIEW OF PREVIOUS RADIONUCLIDE STUDIES
Renal Anatomy and Physiology
The kidneys are paired organs which constitute on the average 0.4% 
of the weight of the body, yet, at rest, renal blood flow amounts to 
20-25% of cardiac output(40). The high blood flow to the kidneys is 
related to the several vital functions the kidneys perform for the body. 
Not only do the kidneys eliminate metabolic waste products, they also 
regulate fluid balance and electrolytes such as sodium and potassium and 
perform some endocrine functions. Figure 1 illustrates some of the basic 
anatomical features of the urinary system, including the distinction 
between the outer portion of the kidney, called the cortex, and the inner 
portion, called the medulla.
To perform its functions, each kidney is composed of approximately 
one million units called nephrons each of which are capable of producing 
urine(28). Each nephron is composed of a glomerulus which filters plasma 
and a tubular portion which functions not only as a conduit but, also is 
responsible for ultimate regulation of fluid and electrolytes.
The anatomy of the nephron is described by following the path of 
the fluid flow through the kidney. Blood enters the kidney in the renal 
artery which branches into a series of successively smaller arteries and 
finally into afferent arterioles each of which leads into the glomerulus 
of a nephron. The capillaries of the glomerulus are suspended in the 
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Figure 1. The basic anatomical features of the urinary system 
from Guyton(28).
capillaries of the glomerulus is higher than the pressure of the 
ultrafiltrate in Bowman's capsule(2), plasma water is filtered through 
the capillary membrane. The epithelium of Bowman's capsule is continuous
with the proximal tubule. Ultrafiltrate from Bowman's capsule first
Fromenters the proximal tubule lying in the cortex of the kidney, 
there, the fluid continues into a sharp hairpin-like loop called the loop
of Henli. Cortical nephrons which make up approximately 85% of all the 
nephrons(4) have glomeruli which are located in the outer cortex and the 
descending loop of Henle protrudes only into the outer medulla. The 
remaining 15% of the nephrons have glomeruli which lie close to the 
medulla with long thin descending portions of the loop of Henle which 
descend deep into the medulla. These nephrons are called juxtamedul1 ary
3
nephrons. The ascending loops of Henle for both types of nephrons
continue up into the cortex into the distal tubule. The distal tubules
of several nephrons then empty into a collecting tubule or collecting 
duct. This duct descends into the medulla paralleling the loops of Henle 
and empties into the renal pelvis. Figure 2 shows the anatomy of
cortical and juxtamedullary nephrons.
The afferent arteriole after branching into the network of
capillaries of the glomerulus recombine to form the efferent arteriole 
which leaves Bowman's capsule only to form a second network of 
capillaries called the peritubular capillaries. Blood perfuses the 
cortical interstitium around both the proximal and distal tubules in the 
peritubular capillaries. Efferent arterioles from glomeruli of 
juxtamedullary nephrons also branch into the medulla. These vessels, 
called vasa recta, are long and descend parallel with the loops of Henle 
deeply into the medulla. The vasa recta then loop back up into the 
cortex and empty into the cortical veins along with the peritubular 
capillaries. Figure 2 also compares the blood supplies of cortical and 
juxtamedullary nephrons.
Filtration, Reabsorption and Secretion
The function of nephrons is to form urine and in doing so clear the 
body of metabolic wastes and regulate sodium, potassium, chloride and 
hydrogen ions(64). The nephrons use three basic processes to accomplish 
this: glomerular filtration, tubular reabsorption and tubular secretion.
Blood perfusing the glomerular capillaries is under hydrostatic 
pressure thereby initiating the formation of urine. Cellular elements, 
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Figure 2. Comparison of the anatomy including the blood supplies 
of cortical and juxtamedullary nephrons. From Pitts (40).
the capillary membrane due to either their size or charge, so that the 
ultrafiltrate appearing in Bowman's space is essentially protein and cell 
free(2). This process is called ultrafiltration. The volume of plasma 
filtered per unit time is known as the glomerular filtration rate (GFR). 
Guyton estimates that one-fifth of the plasma that flows through the 
glomular capillaries is filtered into Bowman's capsule and enters the 
tubular portion of the nephron(28). The nonnal value for the GFR of a
5
70 kg man is 125 ml/min.
Due to the large portion of plasma filtered through the glomeruli 
each day, some process must be used to retain extracellular fluid volume 
and return valuable solutes present in the filtrate to the peritubular 
capillary fluid. This process is called reabsorption. With average 
intake, approximately 99% of the salt and water filtered each day is 
reabsorbed, however, the kidney has tremendous capability to vary this 
percentage considerably in order to maintain homeostasis. The rate of 
reabsorption is the difference between the rate of filtration and the 
rate of excretion. Reabsorption occurs through the tubule walls by both 
active and passive mechanisms. Solutes such as sodium, glucose and 
phosphate require active transport mechanisms, while urea and water are
passively reabsorbed following concentration gradients.
The other process used in urine formation is called tubular
secretion. Secretion is used to transport substances into the tubular
lumen and may be either active or passive. The rate of secretion is 
equal to the rate of excretion minus the rate of filtration. Figure 3
illustrates the three basic processes of urine formation.
Clearance Concept
The clearance of a substance is defined as the volume of plasma
from which that substance is completely cleared by the kidneys per unit
time(65). Plasma clearance varies for different substances and can be
calculated by the following basic formula:
Plasma (ml/min)=Quantity of Anin)*conc. in urine(mg/ml)
Concentration in plasma (mg/ml)






















Figure 3. The three basic processes of urine formation. From
Vander (64).
to measure different aspects of kidney function.
Inulin clearance is one of the most important clearance measure­
ments made. Inulin is metabolically inert, is not protein bound and is 
freely filtered at the glomerulus. Since inulin is neither reabsorbed 
nor secreted by the renal tubules, the amount of inulin excreted in the
final urine is equal to the amount filtered by the glomeruli per unit 
time(2). Therefore, inulin clearance is a measure of glomerular
filtration rate (GFR). The clearance of inulin to measure GFR was first
proposed by Richards, et al and Shannon and Smith in 1935(4). One 
drawback to inulin measurement is that inulin does not normally exist in
7
human plasma and so must be constantly infused to maintain a constant
level in the blood in order to perform the clearance measurement. 
However, creatinine is normally found in human plasma at relatively 
constant levels(2) and exhibits most of the same properties of inulin 
except that it is partially secreted (approximately 20%). This tubular 
secretion of creatinine makes its clearance value proportionately higher 
than that of inulin. In the human adult male, the average normal value 
for inulin clearance is 135 ml/min corrected to 1.73 square meters of 
body surface area, whereas, the average normal creatinine clearance is 
164 ml/min corrected(2).
Para-aminohippuric acid (PAH) clearance is another important
PAH, like inulin,is metabolically inert, 
is not produced by the body, is freely filtered by the glomerulus and is
Unlike inulin, however, PAH remaining in 
the plasma after filtration is almost completely secreted by the 
tubules(41).
measurement of renal function.
not reabsorbed by the tubules.
Since PAH is almost completely cleared by both filtration 
and secretion in a single pass through the kidneys, PAH clearance may be
used as a measure of renal plasma flow. In practice, since the
extraction of PAH in the normal adult man is on the average equal to 
90%(53), the true renal plasma flow is underestimated by PAH clearance. 
Therefore, the term, effective renal plasma flow (ERPF) has been used to 
describe PAH clearance(3). If the extraction ratio for PAH (Epah) is 
known, then the true renal plasma flow (RPF) may be calculated as
follows(3):
RPF = ERPF (ml/min)/EpAH (2)
8
If simultaneous measurement of inulin and PAH is made at low plasma 
PAH levels, then the fraction of plasma filtered through the glomeruli, 
known as the filtration fraction, can be calculated using the following 
equation(41):
(3)Filtration Fraction = Cin/Cpah = GFR/ERPF
In a normal adult man, the filtration fraction is 16-20%(41).
Radionuclide Studies
The clearance studies previously mentioned, utilizing inulin for 
GFR determination and PAH for determining the ERPF, are not routinely 
used clinically due to their demanding, invasive nature. The standard 
urinary clearance technique involves constant intravenous infusion of the 
substance to be measured and bladder catheterization for collection of
urine. This makes the presence of a physician mandatory and the accurate 
collection of blood and urine samples absolutely important. The use of
radioactive tracers substituted for these chemical substances has become
a widespread practice. The goal is to increase the ease and accuracy of 
the analyses, since scintillation counting of a gamma emitting 
radionuclide is faster and easier than chemical analyses(61).
1-131 or 1-123 labeled orthoiodohippurate (OIH) are the most 
commonly used radiopharmaceuticals for the determination of effective
1-131 and 1-123 are both gamma photon emittingrenal plasma flow.
radionuclides with energies of 364 keV and 159 keV respectively.
OIH with gamma photon energies of 28 and 35 keV, has also had limited 
The similarity in renal handling of orthoiodohippurate (OIH) and 




co-workers(55). Smith compared clearance ratios of unlabeled OIH, PAH
and Diodrast and found these ratios to be within .95 to .97 in both dog
and man using urinary clearance techniques developed in his lab.
Realizing the advantages of labeling OIH with a radioactive tag so 
that external measurements could be taken, Tubis, Posnick and Nordyke in 
1960, were first to successfully label OIH with 1-131(63). The following 
year, Mitta et al, simplified Tubis' technique(36).
Urinary Clearance Techniques
Using the urinary clearance techniques of Smith(55), several 
investigators soon reported using the 1-131 labeled OIH to measure 
effective renal plasma flow. Schwartz and Made!hoff(48,49) performed 
simultaneous PAH and radio-OIH clearance studies on twenty-five 
patients in which they found the average Cqih/Cpah clearance ratio to be 
0.814. Burbanke and Tauxe(13), working independently, also compared PAH 
and 1-131 OIH in man and reported an average Cqih/CpaH clearance ratio 
of 0.87. Later, other investigators confirmed these clearance ratios in 
man(7,47).
Several theories have been suggested to explain why radio-OIH has a 
lower clearance than PAH. Burbank(13) suggested that the presence of 
free iodide in the 1-131 OIH may cause the failure to achieve the 
expected ratio of 1.0. However, Meschan et al,(35) reported a low 
clearance ratio with less than 1% free iodide in the preparation. 
Magnusson(32) related the discrepancy to the high specific activity of 
the 1-131 OIH, causing autoradiolysis and a higher free iodide content.
As a result, in 1967, 1-131 was replaced with 1-125 with a lower specific 
activity to tag OIH and higher clearance ratios of 0.90 by Ram et al(43)
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and 0.96 by Cutler and Glatte(16) were reported. Much later in 1980, 
Stadalnick et al(56) tagged OIH to 1-123 and reported a lower OIH to PAH
clearance ratio of 0.86.
A second theory was postulated to explain why 1-131 OIH has a lower 
clearance than PAH. Since OIH is bound to protein by as much as 50% more 
than PAH, Schwartz and Medelhoff(49) suggested that the protein binding 
retards diffusion from the peritubular capillaries to the interstitial 
fluid. Summers et al(58) used protein-free plasma filtrates to calculate 
the 1-131 OIH/PAH clearance ratio in dogs and reported 0.96.
Additionally, by administering stable iodohippurate to take up the 
binding sites. Summers reported a clearance ratio of 0.97. Maher and 
Tauxe(33) used plasma filtrates in man and reported a clearance ratio of
0.92.
Later, Gagnon et al(25), concluded from his studies that the 
presence of PAH alters the clearance of 1-131 OIH by inhibiting tubular 
secretion. This finding accounts for only part of the discrepancy 
between the clearance ratios of 1-131 OIH and PAH during simultaneous
measurements, so that, free iodide or protein binding may account for the 
remaining discrepancy.
Single Injection Techniques
In 1956, Tapi in and co-workers(60) first introduced the 
"radioisotope renogram" which involved a single intravenous injection of 
a radioiodinated substance followed by a continuous recording of the 
radioactivity in the renal area. This led other investigators to develop 
a method of determining ERPF utilizing the single injection technique. 
This method obviated the necessity for constant infusion and bladder
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catheterizations used in the chemical analysis technique of determining 
ERPF. The single injection method is based on the assumption that the 
function being measured will clear the substance after injection into the 
blood and, therefore, the clearance rate becomes a measure of the 
functional). Quantitative estimates of renal function are then 
possible, by the application of parameter estimation techniques to 
compartmental models of the renal system, yielding information not 
obtainable from the conventional renogram.
Early investigators compared the clearance ratios of 1-131 OIH to 
PAH. 1-131 OIH was first measured by using a scintillation well counter 
to count the levels of 1-131 in blood or plasma samples taken serially 
after a single injection while simultaneously measuring PAH clearances by 
the standard urinary clearance technique. Gott and co-workers(27) using 
a one compartment model to analyze plasma curves, reported excellent 
correlation (1-131 OIH/PAH = 1.01) with PAH clearances in man. With
a one-compartment model, Gott assumed that after a single injection, OIH 
came to equilibrium in the blood within minutes and was then cleared from 
the single blood compartment only by the kidneys. Dabaj and Pritchard et 
al(17) extended Gott's work using the one compartment model to find 
that renal blood flow determined by single injection of 1-131 OIH to be 
within 7.6% of direct measurements of flow in dogs. The same group of 
investigators later found the correlation of single injection to PAH 
clearances to be within 5.6% in humans(42).
Blaufox et al, interpreted the disappearance of 1-131 OIH from 
plasma in dogs(10) following the two compartment system of Saparstein(45) 
and a three compartment system. The model predictions for the cardiac
12
and renal curves were compared to actual data obtained by external 
counting with Nal scintillation probes. Blaufox found that both models 
were successful in predicting 1-131 OIH clearance after single injection 
and therefore recommended and later used the simpler two-compartment 
system for analysis of renograms in man(7,9). The two compartment 
model consisted of a blood (heart) compartment and renal (kidneys) 
compartment and assumed only that the OIH in the renal compartment is 
freely available to the plasma.
Other investigators also used a two compartment model to interpret 
curves of 1-131 OIH disappearance in blood to measure effective renal 
plasma flow. Wagoner, Tauxe and Maher(67) using the two-compartment 
model, reported that the ERPF found by the single injection technique was 
an average of 5% less than the standard PAH clearance found in man. The 
same group, Tauxe et al, modified their studies to evaluate compartmental 
analysis for the simultaneous determination of ERPF and GFR using two 
different radiopharmaceuticals(24). Later, Tauxe et al, simplified their 
method of measuring ERPF so that only one plasma sample must be taken 
after a single injection of 1-131 0IH(62), however, this method seemed to 
result in loss of accuracy.
Equations for a three-compartment model, first proposed by 
Matthews(34), in which the urine (bladder) compartment is included, were 
used by Chisholm and co-workers to calculate ERPF using the clearance of 
1-125 OIH by analyzing blood samples from dogs in a scintillation well 
counter(14). These results were also compared with renal blood flow 
measurements directly made in dogs and were found to correlate well.
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Single Injection Techniques using External In-Vivo Counting
Witcofski et al, using two matched scintillation detector probes 
positioned over each kidney was first to propose that external counting 
of 1-131 OIH over the kidneys ("the renogram") could be analyzed to 
provide a measure of renal function(69).
Johnson, extending Witcofski's work, reported methods to determine total 
and differential renal blood flow in man(59).
Later, Tapi in, Dore and
In 1967, Blaufox and co-workers(11) also reported a method to 
measure ERPF in man by external counting, 
probe placed over the head was used to count 1-131 OIH in the blood after
However, one scintillation
a single injection instead of counting over the kidney. The curve 
resulting from the continuous counts over the head was used in a two 
compartment model to calculate ERPF which was correlated with PAH 
clearances (r=0.89).
A similar single injection technique in man was used by Ram, Evans 
and Chisholm(44) utilizing a single compartment model and external 
counting of 1-125 OIH in the blood over the heart. Their results showed 
that although the correlation with standard PAH clearances were 
satisfactory, the absolute values differed. This difference was 
attributed to background activity.
In 1969, Holroyd et al, suggested using the gamma camera for 
obtaining dynamic quantitative information from renogram curves by 
storing data from the gamma camera on magnetic tape for analysis(29,30). 
There are several advantages of using the gamma camera instead of probes 
for obtaining renogram curves, one of which is the elimination of errors 
associated with probe positioning since the field of view of the standard
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gamma camera is twelve inches in diameter. A second important advantage 
is related to the physical performance of the gamma camera. The 
sensitivity of the gamma camera is almost constant in a plane at right 
angles to the camera axis and decreases more slowly than the sensitivity
of a probe, as the distance from the face of the camera increases, 
the kidneys are posterior organs, when posterior views are taken, the 
distance from the face of the camera is small, so that the sensitivity
Since
and resolution are nearly equal for each kidney. Another advantage of 
the gamma camera is that due to the fact that two dimensional sequential 
images are obtained during the renogram, data on the intrarenal transport 
of OIH can be obtained which is impossible with an ordinary probe.
The following is a review of the literature in which renal function 
is evaluated by external counting using gamma cameras.
Schlegel and Bakule used sequential renal scintillation scan data 
recorded on magnetic tape to estimate individual renal function. They 
found a high qualitative correlation with comparative information 
obtained from excretory urography, biopsy and necropsy(46).
Using a modification of Schlegel's work Hayes, Brosman and 
Taplin(31) determined split renal function in dogs using sequential renal 
scintigraphy also recorded on magnetic tape. This method was based on 
quantitation of three areas of interest (left kidney, right kidney and 
pelvic background) during the one to two minute post-injection period of 
1-131 OIH. The advantage of selecting areas of interest, as recommended 
by Farmelant(23), is to exclude unwanted peripheral background activity. 
The percentage of total renal function for each kidney was calculated and 
correlated well (r = 0.974) with the standard constant infusion OIH
15
clearance using individual urine collection techniques. Complicated 
models or computers were not used in this method since only simple ratios 
were calculated, however, absolute values of ERPF were not found.
Chisholm et al(15,51) described a method of measuring differential 
renal plasma flows in man using 1-123 OIH, the gamma camera and a digital 
computer. A region of interest from the gamma camera images located 
centrally and just above the kidneys was used to calculate ERPF by their 
single compartment model. This value was compared to PAH determinations 
indirectly, by using a heart probe to count 1-125 OIH after a single 
injection technique previously described. A correlation coefficient of 
0.963 was calculated for the two sets of data showing that the gamma 
camera can be used to accurately assess ERPF. Tubular transit time was 
estimated using regions of interest for the cortical and medullary 
regions from the gamma camera images of the kidneys. The computer was 
used in this study to flag the regions of interest and subtract a 
normalized background region from them, as described by Britton and 
Brown(12) earlier.
A few years later, a more complicated approach was reported by 
DeGrazia et al(19) using a seven compartment model that considered the 
distribution and rates of exchange of 1-131 OIH into red cells, plasma 
and extravascular compartments, as well as, the tubular cells of the 
kidney. Measurements of individual ERPF, urine flow fraction and tubular 
transport time were reported in forty nine patients with normal and 
abnormal renal function and compared these values with conventional 
split-function techniques using PAH and inulin. This technique used a 
gamma camera electronically split for counting the kidneys and two
16
scintillation probes recording counts from the heart and bladder. The 
data recorded were transmitted by a teletypewriter over telephone lines 
to a computer for processing. The following assumptions were made for 
the computations. After injection of OIH, it is distributed between free 
OIH in plasma, the red cells, plasma proteins, interstitial and 
extracellular spaces. Exchange of OIH between the free and bound state 
is assumed to be rapid; glomerular flow is small; reabsorption does not 
take place; and OIH is cleared before it is efferent to the proximal 
tubular cells.
In DeGrazia's work, no regions of interest were flagged since only 
counts from the probes and each half of the gamma camera could be
As a result, elaborate mathematics totransmitted to the computer, 
correct for "crossover" counts between kidneys were included in the
parameter estimations. In addition, although no specific regions for 
medullary and cortical areas of the kidneys could be flagged, rate
coefficients for the flow of OIH from the tubular cells into the tubular
lumen of each kidney was reported. Tubular transport time, defined by 
DeGrazia as the time delay between tubular cell outflow and renal pelvic 
outflow, was also reported for each kidney.
DeGrazia's procedure was used clinically in Loma Linda's Nuclear 
Radiology department and was found to be unsatisfactory due to obvious 
inaccuracies for some patients. It was at this time that we decided to 
develop our own model to calculate various parameters of renal function 
to replace this procedure in the clinical laboratory. The following 
chapters are a report of this research.
CHAPTER 2
MATHEMATICAL MODEL OF THE RENAL SYSTEM
Description of Model
This model describes the OIH distribution and clearance in the
renovascular system. At this time, it is necessary to consider the 
assumptions made in setting up the mathematical model. The assumptions 
made are the following: a) it is assumed that after introduction into 
the blood stream, OIH is distributed through plasma and red blood cells 
within the first minute after injection(19). OIH, unlike PAH, diffuses 
into the red blood cells which this model takes into account. Burbank et 
al(13) reported 29% binding to red blood cells and Magnusson(32) reported 
an average of 33% binding. Magnusson also reported no binding of OIH to 
plasma proteins(32). It is also assumed that mixing through the blood 
compartment is extremely rapid in relation to removal from this 
compartment, b) It is assumed that OIH is neither destroyed nor produced 
in the body(13). c) It is assumed that OIH is cleared by the kidneys and 
not reabsorbed, d) It is assumed that the rate constants are
proportional to the quantity of tracer material in the anatomic pool. 
Specifically, it is assumed that the rate of uptake by the renal 
parenchyma is proportional to the blood concentration of 1-131 OIH.
We feel this may be assumed since the concentration of 1-131 OIH is kept 
low and the transport capacity of the renal tubules is not likely to be 
exceeded!29).
A five compartment model used in this research is diagrammed in
17
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Figure 4. The first compartment represents the plasma pool that 
participates in OIH exchange with the proximal tubules of the kidneys. 
There are two pathways from compartment one. The first pathway to 
compartment five represents the 1-131 OIH which is not cleared by the 
kidneys due mainly to binding of OIH to red blood cells. The 
differential equations describing the exchange of OIH into and out of the 
plasma and red blood cells are:
d[Q]i/dt = kg * Q5 - (ki + ke) * Ql 
d[Q]5/dt = ke * Ql - ks * Qs 
where, [Q]i and [Q]5 represent the counts from 1-131 OIH detected in the 
plasma and extra-plasma pool respectively. The rate constant ks (min"*) 
represents the proportion of 1-131 OIH per minute flowing from 
compartment five to compartment one, while kg (min”l) represents the 
proportion of 1-131 OIH per minute flowing from compartment one to 
compartment five.
The second pathway from compartment one represents the plasma 
clearance of OIH into the right and left proximal tubular cells. By 
multiplying ki (min"l) by the plasma volume, the volume of plasma cleared 
by both kidneys in one minute is obtained, commonly called the effective 
renal plasma flow. The fraction k2, represents the proportion of 1-131 
OIH going to the left kidney (compartment two) while (l-k2) represents 
the proportion going to the right kidney (compartment three). The 
differential equations describing OIH clearance by the kidneys are: 
d[Q]2/dt = ki * k2 * Ql - k4 * Q2 
d[Q]3/dt = ki * (l-k2) * Ql - k3 * Q3 













Right Kidney IIILeft Kidney II
Bladder
Figure 4. Diagram representing a five compartment model of the 
mammalian renal system. The rate constants P(l), P(2), P(3), P(4), P(5) 
and P(6) shown on the diagram correspond to ki, k2, k3, k4, ks and kg, 
respectively, in the text.
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left and right kidneys respectively.
The fourth compartment represents the bladder. Inputs from the 
right and left kidneys are represented by k3 (min“l) and k4 (min’M 
respectively. The differential equation describing the flow of urine to 
bladder is:
d[Q]4/dt = k4 * Q2 + k3 * Q3 
The rate constant k3 (min"M represents the proportion of OIH in urine 
flowing from compartment three to compartment four. The rate constant k4 
(min-"1) represents the proportion of OIH in urine flowing from 
compartment two to compartment four.
(8).
Solution of Equations
Equations 4-8 were solved using a program package for simulation 
and parameter estimation in kinetic systems developed by D'Argenio and 
Schumitzky(18). This package was written to handle linear and non­
linear, multiple input, multiple output compartment models and allows for 
both rate inputs and bolus type inputs such as is used in the model of 
this research. With this package, any model which can be represented by 
ordinary differential equations and whose inputs are piecewise constant 
or can be simulated by state jump conditions may be used(18).
Programs developed by Shampine and Gordon(50) using the variable 
order, variable step integration routine of the Adam's methods are used 
for solving the differential equations. The adaptive simplex method of 
Nelder and Mead(37) is applied as the parameter estimation procedure to 
solve for unknown parameters ki, k2, k3 and k4. The Nelder-Mead 
procedure minimizes a weighted least squares criterion and has been used 
on noisy data, such as the data encountered in this project, with
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excellent results(18,39).
The package of programs were received on magnetic tape courtesy of 
Dr. Alan Schumitsky at the University of Southern California in Los 
Angeles. All programs were written in Fortran utilizing double precision 
arithmetic and were running on a DEC KL-10 computer at the University of 
Southern California. The programs had to be converted to run on the Data 
General Eclipse S/200 system in the Scientific Computation Facility at 
Loma Linda University Medical Center.
In order to limit the memory requirement for the parameter 
estimation program while maintaining double precision arithmetic, the 
limits for the program variables had to be decreased. The programs now 
allow 5 states, 5 rate inputs, 5 bolus inputs, 5 dose events, 125 total 
observations for all outputs, 5 outputs and 15 model parameters. Many of 
the programs and subroutines had to be divided into smaller sections and 
chained together passing necessary values in data files. Following 
successful loading of the converted programs into the Data General 
Eclipse System, the accuracy of the conversion was verified by comparing 
the results of sample runs provided in D'Argenio and Schumitsky's 
publication(18) to the output from the converted programs.
Inputs to the Model
When working with compartmental analysis, it is common to observe 
the concentration of a substance in one or more compartments as a 
function of time and then try to deduce the parameters of the system from 
the observed behavior of this substance. This compartmental model was 
written to be used in this way with clinical data.
In a nuclear medicine department, a patient is given a bolus
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injection of 1-131 OIH while simultaneously detecting the photons emitted 
by the 1-131 as it passes through different organ systems. Nal (II) 
scintillation detectors are used to detect these photons. In this 
research, two scintillation probes manufactured by Technical Associates
were used, one positioned anteriorly over the heart and the other
Each probe was connected to anpositioned anteriorly over the bladder.
ORTEC single channel analyzer which analyzes each signal for the 1-131
energy and records these counts for specified units of time. The output 
of the heart probe becomes the model input, [Q]i, per unit time. The 
output of the bladder probe becomes the model input, [Q]4, per unit time.
Both inputs [Qli and [Q]4, were corrected for background counts recorded
In addition, a Nal(Tl) scintillationfor each probe prior to injection, 
gamma camera with a high energy collimator, was used to detect 1-131 OIH
as it passes through the kidneys.
The Searle, standard field of view, gamma camera was connected 
through a single channel analyzer and an analog-to-digital converter to a 
NOVA III mini-computer. The computer recorded not only the counts from 
each kidney but also the X-Y position of where each count came from in 
the field of view of the camera. This resulted in a two dimensional
image of the kidneys for each time interval recorded. Typical
acquisition time intervals for a study were for 12 seconds per frame 
acquired for 120 frames. With the computer, recorded kidney images can 
be summed over time and regions-of-interest for each kidney can be 
flagged so that only counts from the left kidney region were used to make 
a time/activity curve and, similarly, only counts from the right kidney 
region were used to make another time/activity curve. A background
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region of interest was also flagged in an area free of other organs such 
as liver or ureters. A time/activity curve for the background region was 
plotted and after normalization for the different size areas for each 
region, the background curve was subtracted from each kidney curve. The 
corrected left kidney time/activity curve was the input [Q]2» The 
corrected right kidney time/activity curve was the input [Q]3. Diagrams 
of regions and examples of time/activity curves can be found in chapter
three.
An input representing counts from a bolus of activity of 1-131 OIH 
was introduced into compartment one at time zero, 
the value of the y-intercept found by extrapolating the time/activity 
curve recorded from the heart probe back to intercept the y-axis at time
The bolus count was
zero.
It should also be noted that inputs [Qli, [Ql2» CQls and CQl4 start 
at one minute. This time lapse allows for deposition of 1-131 OIH into 
erythrocytes at the same time plasma mixing was taking place(19) and also 
insured that the background activities were proportional to the blood 
concentration of 1-131 0IH(29).
Parameters ki through k4, discussed earlier, were the unknowns 
solved for by the parameter estimation routine. The rate coefficients, 
kg and kg, representing flow into and out of compartment five 
respectively have been found by repeated analyses to be similar for all 
situations tested. For this reason, kg was held constant at 1.0/min and 
kg was held constant at 2.5/min. These values were in agreement with 
similar measurements by others(19,32). Since the rate coefficients 
describing flow into and out of compartment five were held constant and
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since it would be very difficult to sample the red cell compartment, the 
input [Qls was initially set to 1.0 for all sample times.
To test this compartmental model, animal experiments were performed 
in which normal and surgically induced abnormal clinical situations were 
tested. The quantitative clearance parameters calculated with the model 
were compared to clearance values obtained in the more conventional PAH 
and inulin clearance studies performed simultaneously. The next chapter 
describes these experiments and reports the results of these analyses.
CHAPTER 3
ANIMAL EXPERIMENTS: TESTING THE MATHEMATICAL MODEL
Design of Experiments
Initially, it was proposed to use female goats as the animal model. 
Goats were chosen because they are tolerant of indwelling catheters for 
prolonged periods of time (66). The experiments were initially set up so 
that by sterile surgery, catheters would be placed in an artery, the
renal veins and both ureters of a goat with normal kidneys. Clearance 
studies and 1-131 OIH renography would then be performed. After 
sufficient recovery, the animal would again undergo surgery to induce an
abnormal kidney condition. The clearance studies and the 1-131 OIH
renography would then be repeated.
could be compared to normal values for the same animal, 
problems of keeping the catheters in the correct position and free from 
clots, as well as, keeping the animal free from infection were
In this way, the abnormal values
However, the
insurmountable and it was decided that an acute model should be used to
replace the chronic model.
Dogs were chosen as the animal model for the acute studies, since
dogs have been successfully used for renal function studies by many
investigators in the past as referenced in Chapter one. To test the 
compartment model, simultaneous standard PAH and inulin clearance studies
for each kidney were run immediately prior to 1-131 OIH renography so 
that clearance parameters calculated by the model could be compared to 
the PAH and inulin clearances. Dogs with normally functioning kidneys
25
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were first to undergo the procedure. Afterwards, several surgically 
induced abnormal conditions were tested, including, total ureteral
obstruction, renal vein occlusion, a segmental infarct by ligating a 
branch of the renal artery, renal artery stenosis and acute renal failure 
induced by injecting a nephrotoxin. When possible the abnormal 
conditions were induced in only one kidney, leaving the contralateral 
kidney unaffected for normal comparison.
Experimental Protocol
Surgical Protocol
Both male and female mongrel dogs ranging in weight between 24 and 
40 kg, were used for these studies. The dogs were anesthetized using 
sodium pentobarbital (30mg/kg body weight) administered intravenously. A
catheter was placed in the jugular vein for administration of drugs and 
replacement of fluids. The abdomen was surgically opened, the bladder 
was dissected and catheters placed into both ureters and tied in place. 
Following a cut-down procedure, under fluoroscopy, catheters were placed 
in the aorta via the left or right femoral artery and in both renal veins 
via the left and right femoral veins. In the animals with both kidneys 
functioning normally, only one renal vein was catheterized. It was 
assumed that the concentration of PAH and inulin would be equal in the 
left and right renal veins of normal kidneys. Saline was then infused to 
achieve a urine flow rate of 1-3 cc/minute.
PAH and Inulin Clearance Studies
The PAH and inulin clearance studies were performed first, to
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prevent radioactive contamination of laboratory equipment. Blood samples
from the arterial and renal veins were drawn and twenty minute urine
collections were made prior to injecting PAH or inulin to be used as 
baseline values for PAH and inulin concentrations. A primary loading 
dose of PAH (8 mg/kg) and inulin (50 mg/kg) was then administered 
followed by a sustained infusion of 0.27 mg/kg/min of PAH and 1.1 
mg/kg/min of inulin (54). After initiation of the infusion doses and a 
thirty minute period for equilibrium, three successive twenty minute
urine collections were obtained. Arterial and renal vein blood samples 
were withdrawn at the mid-point of each urine collection period. Red 
cells and plasma were separated by centrifugation.
Concentrations of PAH and inulin in plasma and urine samples were 
analyzed using standard colorimetric methods (1). The effective renal 
plasma flow for each kidney was calculated from PAH concentrations using 
the following formula from Pitts (41):




U = urine concentration of PAH (mg/dl)
VP = renal vein plasma cone, of PAH (mg/dl)
AP = arterial plasma cone, of PAH (mg/dl)
V = volume of urine collected per minute (ml/min)
Glomerular filtration rate for each kidney was calculated using inulin 
concentrations using the following formula from Pitts (41):
GFRtotal = U * V (10)VP
where.
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U = urine concentration of inulin (mg/di)
VP = renal vein plasma cone, of inulin (mg/dl)
V = volume of urine collected per minute (ml/min)
Radionuclide Studies
Prior to injecting 1-131 OIH, the animal's plasma volume was 
measured by the 1-125 albumin dilution method (21). The hematocrit was 
also evaluated. The animal was placed in a supine position over the 
gamma camera. One Nal (Tl) scintillation probe was positioned over the 
heart and another probe was positioned over the "bladder." Since the 
bladder had been dissected during surgery to insert ureteral catheters, a 
plastic cup into which both catheters drained was used to simulate the 
bladder. A 500 microcurie Tc-99m glucoheptonate dose was then injected 
to localize and position the kidneys to ensure they were in the field of 
view of the gamma camera.
The radionuclide renal clearance study was then performed by 
injecting a bolus of 1-131 OIH (4.4,/^Ci/kg) while simultaneously 
collecting counts from both probes and the gamma camera as the 
radiopharmaceutical passed through each compartment. The data was 
collected in twelve second intervals for twenty-five minutes. The counts 
per 12 seconds from the heart and bladder probes were printed out 
separately to be used as time/activity curve inputs for compartments one 
and four, respectively.
As stated previously, images of the kidneys from the gamma camera
These images were summed andwere recorded on a digital computer, 
regions of interest flagged for each kidney, as well as, a background
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region of interest, as depicted in figure 5. These kidney regions were 
then used to plot time/activity curves corrected for a normalized 
background count. Figure 6 graphically illustrates time/activity curves 
from both kidneys, the heart and bladder from a dog with normally 
functioning kidneys and from a dog with total left ureteral obstruction.
In addition to obtaining time/activity curves from kidney regions 
of interest, additional processing of the computer images of the kidneys 
was done. Each of the 120 images of the kidneys was filtered using 
digital temporal and low-pass spatial filters available on software 
provided on the Medical Data Systems NOVA III minicomputer used in the 
Nuclear medicine department. Through experimentation, using filters of 
various neighborhoods and cut-off frequencies, it was found that for both 
the temporal and low-pass spatial filter, using a neighborhood of 7 and a 
cut-off frequency of .15 cycles/sample eliminated the background counts 
and gave the overall best results. After filtering, a Fourier analysis 
was done on the images. This phase analysis was also available on 
existing software from Medical Data Systems NOVA III minicomputer.
The filtering and Fourier analysis on the series of kidney images 
showed the dynamic pattern of blood flow through the kidneys. The phase 
diagrams were color coded so that counts corresponding to blood activity 
were represented by the same color when found to be at the same phase 
angle. As the phase angle changes, so that the color scale changes, a 
representation of the pattern of blood flow through the kidney was seen. 
This colored pattern can be shown in a dynamic display on the computer.
In these color coded phase diagrams, kidneys with normal function 
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Regions of interest drawn over the left and right kidneys 
with the background region drawn under the right kidney.
Figure 5
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TIME/ACTIVITY CURVES OBTAINED FROM SCINTILLATION 
DETECTORS AS A BOLUS OF 1-131 OIH WAS INJECTED 
INTO DOGS.
NORMAL FUNCTIONING KIDNEYS 
BLADDER
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Figure 6
areas in figure 7, followed by flow to the medullary regions represented 
by the blue areas of the same figure. Figure 7 is the color coded phase 
diagram of a dog in which the left kidney had total ureteral obstruction. 
The normal right kidney showed the characteristic initial blood flow to
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Phase images of normal kidneys. The red areas show initial blood flow to 
the cortex followed by blood flow to the medulla represented by the blue 
areas.
Phase images of kidneys in which the right kidney is normal and the left 
kidney has total ureteral obstruction. The right kidney shows normal 
initial blood flow to the cortex (yellow area) followed by blood flow to 
the medulla (red area). The obstructed left kidney (blue areas) shows 




the cortical region represented by the yellow area, followed by flow to 
the medullary region represented by the red area. The phase diagram 
showed delayed blood flow to the obstructed left kidney compared to the 
normal right kidney. The left kidney was represented as a blue color 
which was completely out of phase with the right kidney.
The time it takes for blood to flow from the cortex to the
medullary region was calculated using the color coded regions of 
interest from the computer to plot time/activity curves. We have called 
the difference in peak times between the cortical curve and medullary 
curve, the cortex-to-medulla transit time. The transit time varied from 
0.8 minutes to 3.2 minutes for the normal kidneys tested. The cortex-to- 
medulla transit time for the measurable abnormal kidneys tested varied 
from 0.6 minutes to greater than 20 minutes. Several of the abnormal 
kidneys had no blood flow through the kidney, therefore, cortex-to- 
medulla transit time could not be measured. Table 5 in a later section, 
lists the calculated cortex to medulla transit times and discusses the
results for the studies reported.
Computer Printout of Model Parameter Estimation Routine
The time/activity curves obtained for both kidneys, the heart and 
bladder were then inputted to a file on the Data General Eclipse S/200 
system to be used by the parameter estimation routines described in 
Chapter 2 to solve for ki, k2, ks and k4 corresponding to P(l), P(2), 
P(3) and P(4), respectively, on the computer printout. Figure 8 was a 
sample printout of a computer run on study number two. After specifying 
the data input file name, the option to print information contained in 
this file was given.
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COMPARTMENT MODEL IDENTIFICATION
ENTER THE INPUT FILE NAME:
MODEL INPUT INFORMATION 
THE NUMBER OF RATE INPUTS:
THE NUMBER OF BOLUS INPUTS:
THE NUMBER OF DOSE EVENTS:







RATE AND/OR AMOUNT FOR ALL INPUTS 
B (1)EVENT
0. 01 4424.00
MODEL OUTPUT INFORMATION 
THE NUMBER OF MODEL OUTPUTS:
THE NUMBER OF OBSERVATION TIMES: 




SUPPLY DATA WEIGHTING INFORMATION 
OUTPUT WEIGHTS
SUPPLY THE WEIGHTS FOR EACH OUPUT, Y(l)-----Y<5>:
1.0,1.0,1.0,1.0,1.0
OBSERVATION WEIGHTS
THE FOLLOWING OBSERVATION WEIGHTING SCHEMES ARE AVAILABLE: 
GENERAL WEIGHTING.
INVERSE VARIANCE OF THE ASSAY WEIGHTING. (LINEAR) 





ENTER THE NUMBER OF THE DESIRED WEIGHTING PROCEDURE: 




ENTER THE NUMBER OF THE DESIRED WEIGHTING PROCEDURE: 




ENTER THE NUMBER OF THE DESIRED WEIGHTING PROCEDURE: 




ENTER THE NUMBER OF THE DESIRED WEIGHTING PROCEDURE: 




ENTER THE NUMBER OF THE DESIRED WEIGHTING PROCEDURE: 
ENTER THE NUMBER OF NON-UNITY WEIGHT OBSERVATIONS: 




Figure 8. Computer printout of the Parameter Estimation Routine.
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SUPPLY MODEL EQUATION INFORMATION
ENTER THE NUMBER OF DIFFERENTIAL EQUATIONS:
ENTER THE COMPARTMENT NUMBER FOR EACH BOLUS INPUT: 









































ENTER MAXIMUM NUMBER OF ITERATION: 






NUMBER OF FUNCTION CALLS = 
ADAPTED PARAMETERS 
P( 1 ) =
P (2) =
P (3) =







CONVERGENCE HAS BEEN ACHIEVED
NUMBER OF ITERATIONS = 












Figure 8 - cont.
36
Observation weighting scheme 1 was then selected. The general weighting 
scheme allows the user to enter directly the observation numbers and the 
associated weights for any or all of the observations. Since there was 
more than one compartment sampled, it was necessary to assign a weight to 
each output since each may represent different quantities or may be 
measured on different scales. A weight of unity was given to all 
observations unless specified otherwise. Since the red cell compartment 
cannot be sampled, observations for compartment five were inputted at a 
value of 1.0. The weights for these observations were then set to zero so 
as not to affect the other parameter estimates. The general weighting 
scheme was chosen as recommended for observations which have a constant
variance (18).
The number of differential equations, the compartment number for 
the bolus report, estimates for each parameter and the option to adapt 
each parameter was then inputted.
A summary of the iteration after convergence was achieved, was then 
printed out. Values for the four adapted parameters were given.
Results and Discussion of Parameter Estimates
Table 1 is a listing of the values for each of the four parameters 
calculated for all of the studies reported, 
the two parameters, P(3) and P(4), it was found that when running the 
parameter estimation routine after fixing P(3) and P(4) at values ranging 
from .05 to 1x10"^ for various studies, that values less than .01, for 
either parameter had no affect on values estimated for the remaining 
Therefore, estimated values less than .01 for parameters
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This change affected studies 8, 9,P(3) and P(4) were reported as .01.
10, and 16 for parameter P(4).
The mean value and standard deviation at the 95% confidence level 
for P(l) for the normal studies 2-7 was reported to be .337 jK040 min"l. 
The remaining values for P(l) for the abnormal studies decreased
corresponding to a decreased total effective renal plasma flow.
The mean value and standard deviation at the 95% confidence level
for P(2) and 1-P(2) for the normal studies 2-7 was reported to be .500+ 
.106. These parameters, representing the fraction of total effective 
renal plasma flow to the left and right kidney, respectively, were 
expected to be .5 since half the blood flow was expected to go to each 
kidney for normal function. The values for P(2) for the abnormal kidneys 
were decreased significantly, as expected with corresponding increases in 
the fraction of total to the right kidney. Parameters P(l), P(2) and 
1-P(2) will be discussed in more detail in the next section.
The mean value and standard deviation at the 95% confidence level
for P(3) and P(4) for the normal studies was reported to be .461j^ .10 
min"l. These parameters which were proportional to the urine flow from 
the right and left kidneys respectively, decreased for the abnormal
studies as expected. P(3) and P(4) will also be discussed in more detail
in the next two sections.
Results and Discussion of Predicted Effective 
Renal Plasma Flow Estimates
Table 2 compares the PAH clearances to the ERPF's predicted by the 
model and Table 3 gives the results of the inulin clearance tests, 
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3.26 ml/min/kg from Smith (52). The normal value for inulin clearance 
for female dogs was reported to be 4.3 + 1.01 ml/min/kg from Smith (52).
It was assumed that similar to humans, the PAH and inulin clearances for 
male dogs would be higher. The mean value and standard deviation at the 
95% confidence level for the PAH clearance in the three normal male dogs 
evaluated in this study was 16.5_+4.3 ml/min/kg and 15.9_+2.5 ml/min/kg in 
two normal female dogs studied. The range of PAH clearances in normal 
female dogs found in this study was within the reported normal range found 
in the literature. Two dogs evaluated for this study as normals were not 
included in the data since the laboratory analyses for PAH were in error 
and the PAH clearances calculated, far exceeded the normal range.
Comparing the predicted ERPF's to the PAH clearances, for normal 
and abnormal studies 2-16, we found the correlation coefficient, r, to be
0.88. The study with the largest difference between the PAH clearance 
and the predicted ERPF was study number 13. Excluding number 13, the
correlation coefficient for studies 2-16 was 0.92. We were unable to
determine the reason for such a large error for study number 13. 
Therefore, it was repeated.
For studies 8, 9, 10, 14 and 16, the surgically induced abnormality 
to the left kidneys caused these kidneys to become anuric. Since the 
analytical analyses for PAH and inulin clearances depend on urine 
concentrations, no PAH and inulin clearances could be calculated for the 
above mentioned studies.
In study number 8, total left ureteral obstruction was produced by 
ligating the ureter from the left kidney. The right kidney was normal. 
The basic mechanism for altered renal function in urinary tract
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obstruction was a decrease in urine flow and an increase in pressure in 
the renal tubule, resulting in decreased ERPF and glomerular filtration 
(68). As expected, the PAH clearance was markedly decreased. The 
predicted total ERPF was also markedly decreased, following the PAH 
clearance. The left kidney PAH clearance could not be calculated due to 
postrenal anuria. The model predicted an abnormally low left kidney ERPF 
as expected and normal right kidney ERPF. Also as expected, the model 
predicted a very small value for P(4), which represents urine flow from 
the left kidney. In this study, the blood flow to the left kidney was 
somewhat reduced while the urine flow from the left kidney was drastically
reduced.
In study number 9, total left renal vein occlusion was surgically 
induced by ligating the left renal vein. The right kidney was normal. 
Renal vein occlusion has been known to cause a decline in renal function
by decreasing both the ERPF and GFR with resulting oliguria and anuria 
for the affected kidney (20). The degree of decline in renal function was 
largely dependent on the degree of the occlusion. As expected in this 
study, the PAH clearance was reduced, followed by a reduced predicted 
ERPF. The left kidney PAH clearance could not be calculated since no 
urine was produced. The predicted left kidney ERPF was drastically 
reduced (10% of normal) while the predicted right kidney ERPF was normal. 
In addition, P(4) was also a very small value, predicting very little 
urine flow from the left kidney as would be expected with severely
The GFR of the right kidney was elevated which
In this study, both the
reduced kidney function, 
may be a response to the left kidney problems.
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blood flow to the left kidney and the urine flow from the left kidney 
were both drastically reduced.
In study number 10, total left renal vein occlusion was surgically 
induced by ligating the left renal vein, similar to study number 9.
Again as expected, the predicted total ERPF was reduced, however no PAH 
or inulin clearance could be calculated for comparison since the catheter 
placed in the right renal vein became clotted and no urine was produced 
from the left kidney. The predicted left kidney ERPF was again 
drastically reduced (15% of normal) with a very small value of P(4) 
representing little urine flow from the left kidney. These results 
compare favorably to the results found in study number 9, showing 
consistency in the model predictions.
In addition, for study number 10, a segmental infarct to the right 
kidney was induced by ligating a branch of the right renal artery. An 
infarct results in a loss of renal function shown by a decrease 
in the ERPF accompanied by a decrease in urine output (20). The degree 
of decline in renal function depends on the degree of the infarct. Since 
we do not have a PAH clearance for the right kidney, we have no 
comparison for the predicted right kidney ERPF. A comparison with other 
kidneys in which segmental infarcts were induced will be made in a later 
section discussing the blood to urine flow index.
In study number 12, renal artery stenosis was induced in the left 
kidney by partial clamping of the left main renal artery. The clamp was 
tightened on the left artery until the urine output from the left kidney 
was reduced to one third of the urine output from the right kidney.
Using a flowmeter, the stenosis was estimated to be 65-75%. The right
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kidney was normal in this study. Mild to moderate unilateral renal 
artery stenosis may cause little or no change in total renal function as 
determined by inulin and PAH clearance tests however, diminution of
urinary volume may occur and become more marked as the stenosis becomes
\
more severe (20). As the stenosis becomes more severe, the decrease of 
ipsilateral blood flow was countered by an increase in blood flow to the 
contralateral kidney (20). Using conventional radio-renograms, unless 
the stenosis was quite severe, 80% or more, no changes are seen in the 
renogram curves (5). The total PAH clearance for study number 12, was 
moderately reduced with the left PAH clearance being reduced while the 
right kidney PAH clearance was elevated slightly. Also, the left kidney 
inulin clearance (GFR) was reduced while the right kidney inulin clearance 
(GFR) was elevated. As explained above, this may be expected for a severe 
stenosis. The predicted total ERPF was reduced following the PAH 
clearance. However, the predicted left kidney ERPF was not reduced as 
much as the corresponding left PAH clearance and the predicted right 
kidney ERPF was not elevated as was the corresponding right PAH clearance. 
The parameter, P(4), representing left urine flow, was less than P(3), 
representing right urine flow, which may be expected for stenosis. One 
explanation for these differences in predicted ERPF and PAH clearances was 
that the radionuclide evaluation may not be as sensitive as the chemical 
evaluations. As stated earlier, unless a severe stenosis of at least 
80% was present, little or no changes are seen in the radionuclide curves. 
Although the model predicted some decreased left kidney function, the 
model may be limited in evaluating less severe degrees of renal artery
stenosis.
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In study number 13, a segmental infarct to the left kidney was 
induced by ligating a branch of the renal artery, similar to the right 
kidney of study number 10. The right kidney for study number 13 was 
normal. The PAH clearance was drastically reduced (less than half of 
normal) whereas, the predicted total ERPF was only slightly reduced from 
normal. A 55% difference in these values was noted, however, no reason 
for this large difference could be attributed except for a possible error 
in the laboratory PAH analysis or overestimation by the model. The PAH 
clearance and predicted ERPF for the left kidney both showed reduced 
function compared to the right kidney. In addition, the inulin clearance 
for the left kidney was reduced as expected. The parameter, P(4), was also 
reduced representing decreased urine flow from the left kidney. In this 
study, the PAH clearance and predicted ERPF, both showed decreased left 
kidney function as expected, however, the precision of the quantitative 
comparisons was not good. The study was repeated for this reason in 
study number 15.
In study number 15, again a segmental infarct to the left kidney 
was induced. The total PAH clearance was slightly reduced as expected.
The predicted total ERPF was also slightly reduced corresponding to the 
decrease in blood flow to the left kidney. For this study, the values 
for PAH clearance and ERPF agreed quite well. The difference in these 
values was small (6%) providing a higher precision than for study number 
13 and still followed the pathology as well. The left kidney PAH 
clearance and predicted ERPF agreed and both showed decreased blood flow 
to the left kidney as expected. The right kidney values were within the 
normal range. The left kidney GFR was not reduced as expected. The
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parameter, P(4), was also slightly reduced corresponding to a reduced 
urine flow from the left kidney as expected, due to decreased function. 
In study number 14, acute renal failure was induced by injecting a
nephrotoxin. The nephrotoxin used for this study was uranyl nitrate. 
Acute renal failure was induced as recommended by Flamenbaum, by 
injecting uranyl nitrate, 10 mg/kg body weight, in a saline solution 
(22). Since unilateral acute renal failure was the objective, uranyl
nitrate at the above dose level, was slowly injected into the left renal 
artery via a catheter placed under fluoroscopy. Immediately after the 
injection, fluoroscopy of the left kidney was performed. At this time, 
it was observed that the left kidney was in total acute renal failure.
The possibility was noted that the nephrotoxin refluxed systemically and 
so affected the right kidney. Acute renal failure induced by uranyl 
nitrate is characterized by a decrease in both ERPF and GFR accompanied 
by oliguria and anuria (22). After studying the data from Flamenbaum 
(22), it was decided to perform the clearance studies and 
radio-renography twenty four hours after injection of the uranyl nitrate 
because all function parameters seemed to be reduced significantly by 
this time without large changes after twenty four hours. The left kidney 
was anuric at twenty four hours. As a result, PAH and inulin clearances 
could not be calculated for the left kidney. The right kidney had 
reduced urine output at twenty four hours. The PAH and inulin clearances 
for the right kidney were severely reduced as was the predicted ERPF, 
confirming that uranyl nitrate refluxed into the systemic circulation and 
affected the right kidney. The 1-131 0IH renography recorded no activity 
in the left kidney. The input to the model for the left kidney
47
was therefore zero for all time intervals sampled, 
predicted left kidney ERPF was zero.
As a result, the 
The parameter, P(4), was zero 
representing no urine flow from the left kidney and the parameter, P(3),
was reduced corresponding to reduced urine flow from the right kidney.
In this study, a severe acute renal failure was induced inadvertantly 
affecting both kidneys. However, the model followed the pathology quite 
well. This study was repeated to test unilateral acute renal failure.
In study number 16, unilateral acute renal failure was induced by 
injecting a quarter of the previously injected dose (2.5 mg/kg) of uranyl 
nitrate into the left renal artery. Fluoroscopy of the left kidney 
showed decreased function immediately, however, refluxing into the 
systemic circulation was not observed. Twenty four hours later, the left 
kidney was not producing urine, therefore, PAH and inulin clearances 
could not be calculated. The right kidney had normal urine output. The 
1-131 OIH renography showed a small amount of activity in the left 
kidney. The predicted left kidney ERPF was severely reduced, while the 
predicted right kidney ERPF was within the normal range and agreed with 
the right kidney PAH clearance. The parameter, P(4), was reported as a
very small value indicating very little urine flow from the left kidney. 
P(3) was within the normal range. The GFR calculated for the right
kidney was reduced which may be explained if unobserved reflux of the 
nephrotoxin into the systemic circulation took place, 
which unilateral acute renal failure was produced, the model followed the
In this study, in
pathology predicting a decreased ERPF and decreased urine flow from the 
left kidney while the right kidney was predicted as normal.
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Results and Discussion of the Blood-to-
Urine Flow Index
The Blood-to-Urine Flow Index for each kidney was being defined in 
this research as the ratio of the model parameters which indicate blood 
flow into the kidney versus the urine flow out of the kidney. For the 
left kidney, the Blood-to-Urine Flow Index was equal to P(2)/P(4). For 
the right kidney, the Blood-to-Urine Flow Index was equal to 1-P(2)/P(3). 
Table 4 is a listing of these ratios calculated for all reported studies. 
The mean value for the normal kidneys with the standard deviation at the 
9S% confidence level was 1.40 + 1.02. The normal kidneys included in this 
mean are the left kidneys for studies 2-7 and the right kidneys for
studies 2-16 excluding studies 10 and 14. All normal kidneys had 
reported flow indexs within two standard deviations of the mean.
In study number 8 (left total ureteral obstruction), the blood flow 
into the left kidney decreased slightly while the urine flow was severely 
reduced. As a result, the left kidney flow index was very high, equal to
25 times above the mean.
In study number 9 (left total renal vein obstruction), both the 
blood flow into the left kidney and the urine flow out of the kidney were
severely reduced with the urine flow more reduced than the blood flow.
The resulting flow index was therefore higher than normal, seven times 
above the mean, but not as high as in study number 8.
In study number 10, the flow index for the left kidney (also with 
total renal vein occlusion) agreed with the left kidney flow index 
calculated in study number 9. 
differentiating the two conditions induced in the left kidneys of studies
The flow index was very successful in
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However, these studies represent extreme conditions, 
therefore, for less severe ureteral obstruction or renal vein occlusion, 
there will probably be a range of overlap in the values calculated for
8, 9 and 10.
the flow index.
Also in study number 10, the right kidney (renal artery branch 
occlusion) showed both decreased ERPF and urine flow. In this condition,
both parameters were decreased proportionately. As a result, the flow 
index was within the normal range as might be expected. This was also true 
for study numbers 13 and 15 in which left renal artery branch occlusion
was induced.
In study number 12 (left renal artery stenosis), the left kidney 
showed a slightly decreased ERPF and decreased parameter for urine flow. 
With renal artery stenosis, as in study numbers 10 and 12, both 
parameters were decreased proportionately. Therefore, the flow index for 
the left kidney was within the normal range.
In study number 14, both kidneys were affected by the nephrotoxin. 
The left kidney was in total acute renal failure and the flow index was 
zero. In the right kidney, the urine flow was reduced more than the ERPF 
resulting in a higher than normal flow index, six times above the mean.
In study number 16, the left kidney was affected more by the nephrotoxin. 
This kidney had an even lower urine flow with reduced ERPF resulting in a
higher value for the flow index, ten times the normal mean.
Results and Discussion of the Cortex-to-Medulla
Transit Time
The cortex-to-medulla transit time as discussed in a previous 
section was the peak to peak time difference of the cortex and medulla
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time/activity curves. Table 5 lists the transit times for the reported 
studies. The mean value for the normal kidneys with the standard 
deviation at the 95% confidence level was 1.37 + .660 minutes. The normal
kidney values included in this mean were the left kidney transit times for 
studies 2-7 and the right kidney transit times for studies 2-16, 
excluding studies 10 and 14. All normal kidneys had reported transit 
times within two standard deviations of the mean, except the right kidney 
of study number 6. This variation may be due to the low counts observed 
for the cortex and medulla areas causing errors in the flagging process 
for obtaining the time/activity curves which were used for peak time 
determination.
In study number 8 (left ureteral obstruction), the transit time was 
delayed probably due to the increased pressure caused by the obstruction.
In studies 9 and 10 (left renal vein occlusion), the counts 
observed in these kidneys were very low so that the cortex and medulla
The transit times are reported as 
infinity since the small amount of activity entering the kidney was not 
1eaving.
could not be differentiated very well.
In the right kidney of study number 10 and the left kidney of study 
number 13 in which segmental infarcts were induced, the transit times 
were within the normal range as might be expected since the 1-131 0IH 
flowing through the unaffected segments of these kidneys was cleared 
normally. However, in study number 15, in which a segmental infarct had 
also been induced, the transit time was delayed, contradicting the above 
findings, but most likely due to low counting statistics.
In study number 12 (left renal artery stenosis), the transit time
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was within the normal range of values. This might be expected for a 
moderate stenosis since little change in the renogram curve was
observed.
In study number 14, in which both kidneys were affected by the 
nephrotoxin, no activity was observed in the left kidney, therefore, the 
transit time was reported as infinity. The activity seen in the right 
kidney of study number 14 stayed in the cortex, therefore, the transit 
time was reported as infinity for this kidney also.
In study number 16 (left kidney acute renal failure induced by a 
nephrotoxin), the transit time for the left kidney was delayed at ten 




The model simulates OIH distribution and clearance in the
renovascular system. This mathematical analysis describes the renal 
system as five compartments; the blood, left and right kidneys, bladder 
and the red blood cell compartment. The model takes into account the OIH 
trapped in the red blood cell compartment, even though this compartment 
cannot be directly monitored.
Data for the blood, kidney and bladder compartments are collected 
with scintillation detectors monitoring OIH tagged with 1-131 as the 
radio-pharmaceutical passes through each compartment. The kidney data 
from the gamma camera are acquired onto a computer so that flagged 
regions of interest can be used to plot time/activity curves for each 
kidney. The heart, bladder and kidney data are then used as inputs to 
the model parameter estimation routine.
The compartments are described by a set of first-order ordinary 
differential equations. A method developed by Shampine and Gordon (50) 
using the Adam's methods is used to solve the equations. For parameter 
estimation, a method is used as developed by D'Argenio and Schumitsky 
(18) using an iterative predictor-corrector procedure. A Data General 
Eclipse S/200 system is used to carry out these calculations.
The estimated model parameters are used to calculate the 
quantitative values of total, left and right kidney effective renal
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plasma flows. Two parameters are used as indications of urine flow. In
addition, the Blood-to-Urine Flow Index is defined in this research using
these parameters and is an indication of individual renal function. A
cortex-to-medulla transit time is calculated using a Fourier analysis of 
the kidney images stored on the computer.
To verify the accuracy of the model, animal studies were done in 
which various kidney abnormalities were surgically induced 
abnormalities induced included, ureteral obstruction, renal vein
The
occlusion, segmental infarcts, arterial stenosis and acute renal failure. 
The quantitative clearance parameters calculated by the model were then 
compared to clearance values received in PAH clearance studies performed
simultaneously. Inulin clearances were also performed to substantiate
the abnormalities.
Conclusions
Using this model, quantitative clinical estimates of renal function 
are possible. In addition, indications of urine flow, a Blood-to-Urine 
Flow Index, and cortex-to-medulla transit times are compared to help 
identify abnormal renal conditions which may be encountered in a clinical 
situation. Images obtained of the kidneys are helpful in identifying 
gross morphology.
The model predicts decreased effective renal plasma flow for all 
the abnormal conditions tested as expected. The predicted ERPF's 
decreased porportional to the degree of abnormality in the kidneys and 
correlated with an r = .88 with PAH clearances. The precision for these 
comparisons were not as good as might be expected. This limitation may 
be due to the accuracy of the laboratory analyses. The urine flows for
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all the abnormal conditions were also decreased proportional to the
degree of abnormality as expected.
Of particular interest is the Blood-to-Urine Flow Index. The flow
index was successful in differentiating two conditions which are normally
difficult to identify. These two conditions are ureteral obstruction and
renal vein occlusion. Clinically, this could be very helpful in 
screening patients with renal problems. The flow index is also abnormal 
when acute renal failure is present. However, since some of the
conditions induced in this research were extreme conditions, we feel that
further studies should be done investigating such conditions as partial 
ureteral obstruction and partial renal vein occlusion. These studies 
would help to identify the limitations of the flow index and are planned
in further research.
One of the abnormalities studied in this research, renal artery
However, thestenosis, was not predicted precisely by the model.
stenosis induced was moderate which makes detection difficult.
Therefore, further study using more severe degrees of stenosis is also 
planned in further research.
Finally, in the future, we hope to use this model in a clinical 
nuclear medicine department to aid clinicians in diagnosing renal
disease.
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